NCT04380103 A Phase I/II Study of XELOXIRI and Bevacizumab as First-line Treatment in Metastatic Colorectal Cancer Status UNKNOWN Phase PHASE1/PHASE2
NCT04355858 Molecularly Targeted Umbrella Study in Luminal Advanced Breast Cancer Status UNKNOWN Phase PHASE2
NCT04330664 Adagrasib in Combination With TNO155 in Patients With Cancer (KRYSTAL 2) Status COMPLETED Phase PHASE1
NCT04319757 ACE1702 in Subjects With Advanced or Metastatic HER2-expressing Solid Tumors Status COMPLETED Phase PHASE1
NCT04295863 Comparing Dosing Intervals of Nivolumab or Pembrolizumab in Locally Advanced or Metastatic Cancers Status RECRUITING Phase PHASE1
NCT04260802 A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers Status TERMINATED Phase PHASE1/PHASE2
NCT04257162 HER2-PREDICT: Translational Study of Tumor Samples From Patients Treated With Trastuzumab Deruxtecan (T-DXd; DS-8201a) Status ACTIVE_NOT_RECRUITING Phase NA
NCT04208958 Study of VE800 and Nivolumab in Patients With Selected Types of Advanced or Metastatic Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT04200963 A Phase 1a/b Study of IK-175 as a Single Agent and in Combination With Nivolumab in Patients With Locally Advanced or Metastatic Solid Tumors and Urothelial Carcinoma Status COMPLETED Phase PHASE1
NCT04194528 S1916 Digital Medicine Program for Pain Control in Cancer Patients Status TERMINATED Phase NA
NCT04184518 Durvalumab (MEDI4736) Plus Cediranib in Patients With Metastatic Uveal Melanoma Status WITHDRAWN Phase PHASE2
NCT04143230 Identification of In-hospital Patients in Need of Palliative Care Using a New Simplified Screening Tool Status COMPLETED Phase NA
NCT04141397 Real-world Clinical Effectiveness of Whole Genome and Transcriptome Analysis to Guide Advanced Cancer Care Status UNKNOWN Phase N/A
NCT04105062 LS301 Uptake in Tumors of Patients Undergoing Liver, Pancreas, or Gastric Surgery Status WITHDRAWN Phase PHASE1/PHASE2
NCT04090528 pTVG-HP DNA Vaccine With or Without pTVG-AR DNA Vaccine and Pembrolizumab in Patients With Castration-Resistant, Metastatic Prostate Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2